<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29616" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Subclinical Hypothyroidism</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gosi</surname>
            <given-names>Shiva Kumar Y.</given-names>
          </name>
          <aff>Banner Thunderbird Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaur</surname>
            <given-names>Jasleen</given-names>
          </name>
          <aff>HealthPartners, Minneapolis</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Garla</surname>
            <given-names>Vishnu V.</given-names>
          </name>
          <aff>University of Mississippi Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shiva Kumar Gosi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jasleen Kaur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vishnu Garla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>15</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29616.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Subclinical hypothyroidism&#x000a0;characteristically presents with normal thyroxine (T4) levels and elevated thyroid stimulating hormone (TSH) levels.&#x000a0;The incidence of subclinical hypothyroidism is estimated at 3% to 15%, depending on the population studied. Minor fluctuations in T4 levels result in considerably larger fluctuations in TSH levels. Although TSH levels exhibit wide variability across the population, intra-individual variation remains minimal, which is secondary to a unique individual setpoint within the hypothalamic-pituitary axis for each person.&#x000a0;This condition correlates with an increased risk of fatal and non-fatal coronary artery disease events, congestive heart failure, and fatal stroke. This activity reviews the evaluation and management of subclinical hypothyroidism, emphasizing the collaborative role of the interprofessional healthcare team in enhancing patient care.&#x000a0;This activity also helps clinicians gain&#x000a0;insights into distinguishing characteristics within relevant literature to maximize patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical features and laboratory parameters indicative of subclinical hypothyroidism in patients, including elevated levels of thyroid-stimulating hormone and normal free thyroxine (T4).</p></list-item><list-item><p>Screen at-risk populations, such as individuals with a family history of thyroid disorders, for subclinical hypothyroidism using appropriate laboratory tests.</p></list-item><list-item><p>Select the most suitable thyroid hormone replacement regimen and dosing strategy for patients with subclinical hypothyroidism, considering factors such as age, comorbidities, and medication adherence.</p></list-item><list-item><p>Collaborate with endocrinologists, primary care physicians, and other healthcare professionals to ensure shared decision-making and optimize the care for patients with subclinical hypothyroidism.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29616&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29616">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29616.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Subclinical hypothyroidism&#x000a0;characteristically presents with normal thyroxine (T4) levels and elevated thyroid stimulating hormone (TSH) levels.<xref ref-type="bibr" rid="article-29616.r1">[1]</xref> Minor fluctuations in T4 levels result in considerably larger changes in TSH levels.<xref ref-type="bibr" rid="article-29616.r2">[2]</xref> Although&#x000a0;TSH levels exhibit wide variability across the population, intra-individual variation remains minimal, which is&#x000a0;secondary to a unique individual setpoint within the hypothalamic-pituitary axis for each person.<xref ref-type="bibr" rid="article-29616.r3">[3]</xref>&#x000a0;</p>
        <p>Most individuals have a log-linear relationship between TSH and T4. Still, some individuals can have a nonlinear relationship explaining the normal free T4 with TSH &#x02265;10 mIU/L, while others may have a low T4 level.<xref ref-type="bibr" rid="article-29616.r4">[4]</xref>&#x000a0;Various studies have reported the incidence of subclinical hypothyroidism to be estimated at 3% to 10% and increasing to 18% to 20% in older patients, depending on the population studied.<xref ref-type="bibr" rid="article-29616.r5">[5]</xref><xref ref-type="bibr" rid="article-29616.r6">[6]</xref>&#x000a0;The&#x000a0;prevalence of subclinical hypothyroidism tends to be higher in women and older adults.<xref ref-type="bibr" rid="article-29616.r7">[7]</xref>&#x000a0;Observational studies have shown that subclinical hypothyroidism (with TSH &#x02265;10 mIU/L) correlates with an increased risk of fatal and non-fatal coronary artery disease (CAD) events, congestive heart failure, and fatal stroke.<xref ref-type="bibr" rid="article-29616.r8">[8]</xref><xref ref-type="bibr" rid="article-29616.r9">[9]</xref><xref ref-type="bibr" rid="article-29616.r10">[10]</xref></p>
        <p>The prevalence of this disorder is bound to increase due to the increased availability of high-sensitivity thyroid function testing. Levothyroxine&#x000a0;is the second most commonly prescribed medication in the United States.<xref ref-type="bibr" rid="article-29616.r11">[11]</xref>&#x000a0;The increased recognition and treatment or trials with levothyroxine replacement therapy in patients with subclinical hypothyroidism could partly explain why. A study from the United Kingdom showed an increased trend toward treating hypothyroidism between 2005 and 2014, from 2.3% to 3.5% of the total population.<xref ref-type="bibr" rid="article-29616.r12">[12]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-29616.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Subclinical hypothyroidism and hypothyroidism share the same etiologies. Worldwide, iodine deficiency is the most common cause of hypothyroidism. However, autoimmune thyroiditis (Hashimoto thyroiditis) is the most common cause of hypothyroidism in the United States. Other causes include post-surgical or post-ablative hypothyroidism, central hypothyroidism, and medication-induced hypothyroidism (lithium, amiodarone, checkpoint inhibitors, and tyrosine kinase inhibitors).<xref ref-type="bibr" rid="article-29616.r13">[13]</xref><xref ref-type="bibr" rid="article-29616.r14">[14]</xref>&#x000a0;Higher levels of TSH also occur in individuals with obesity, with TSH levels declining with weight loss.<xref ref-type="bibr" rid="article-29616.r13">[13]</xref><xref ref-type="bibr" rid="article-29616.r15">[15]</xref><xref ref-type="bibr" rid="article-29616.r16">[16]</xref></p>
      </sec>
      <sec id="article-29616.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of subclinical hypothyroidism varies from 3% to 15% based on the study population.<xref ref-type="bibr" rid="article-29616.r13">[13]</xref><xref ref-type="bibr" rid="article-29616.r17">[17]</xref>&#x000a0;Statistical research demonstrates a higher incidence of subclinical&#x000a0;hypothyroidism in women and&#x000a0;older individuals. Individuals with type 2 diabetes mellitus are also more likely to develop subclinical hypothyroidism.<xref ref-type="bibr" rid="article-29616.r18">[18]</xref>&#x000a0;Vanderpump et al, in the Whickham survey,&#x000a0;found 8% of women and 3% of men have subclinical hypothyroidism.<xref ref-type="bibr" rid="article-29616.r6">[6]</xref>&#x000a0;The risk of subclinical hypothyroidism progression to overt hypothyroidism is 2% to 6% per year.<xref ref-type="bibr" rid="article-29616.r13">[13]</xref>&#x000a0;This rate is 3% to 8% in individuals with TSH &#x0003e;10 mIU/L and thyroid peroxidase (TPO) antibody (TPOAb) positivity.<xref ref-type="bibr" rid="article-29616.r19">[19]</xref>&#x000a0;The risk of progression to overt hypothyroidism is higher in women, individuals with higher levels of TSH, and individuals with TPOAb positivity.<xref ref-type="bibr" rid="article-29616.r19">[19]</xref><xref ref-type="bibr" rid="article-29616.r20">[20]</xref></p>
        <p>Subclinical hypothyroidism resolved spontaneously in 46% of&#x000a0;older participants after&#x000a0;4 years in a prospective study involving 459 individuals aged 65 and older. In another study involving 107 women and men aged 55 or older, spontaneous normalization of TSH occurred in 52% of the participants with TSH &#x0003c;10 mIU/L after a mean follow-up of 32 months.<xref ref-type="bibr" rid="article-29616.r21">[21]</xref>&#x000a0;Individuals with TSH &#x0003c;7 mIU/L and TPOAb negativity were more likely to have this resolution.<xref ref-type="bibr" rid="article-29616.r20">[20]</xref></p>
      </sec>
      <sec id="article-29616.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Subclinical hypothyroidism is asymptomatic most of the time. However, it can present with symptoms of hypothyroidism.<xref ref-type="bibr" rid="article-29616.r13">[13]</xref>&#x000a0;Assessing hypothyroid symptoms influences whether thyroid replacement therapy is indicated. The clinical features of hypothyroidism are&#x000a0;as follows:<xref ref-type="bibr" rid="article-29616.r22">[22]</xref><xref ref-type="bibr" rid="article-29616.r14">[14]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Integumentary: Dry skin, hair loss, loss of an outer third of eyebrows, and facial puffiness.</p>
          </list-item>
          <list-item>
            <p>Respiratory: Sleep apnea and hoarseness of voice.</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal: Constipation, dysphagia, loss of appetite, and cholelithiasis.</p>
          </list-item>
          <list-item>
            <p>Cardiovascular: Diastolic hypertension, bradycardia, pericardial effusions, decreased cardiac output, and dyslipidemia, which occur only in severe and sustained hypotension cases.</p>
          </list-item>
          <list-item>
            <p>Neurological: Decreased attention span, pseudodementia, and entrapment neuropathies, with carpal tunnel syndrome being the most frequently encountered.</p>
          </list-item>
          <list-item>
            <p>Musculoskeletal: Muscular weakness, cramps, stiffness, and fatigue.</p>
          </list-item>
          <list-item>
            <p>Reproductive: Irregular periods, menorrhagia, and decreased libido.</p>
          </list-item>
          <list-item>
            <p>Metabolic: Weight gain, cold intolerance, and hyponatremia.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29616.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The hallmark laboratory finding of subclinical hypothyroidism is an elevated TSH with a normal T4. However, non-thyroidal illness and some medications can cause an elevation of TSH, and they need to be ruled out before a diagnosis of subclinical hypothyroidism is established. In patients with TSH &#x0003c;10 mIU/L and normal free T4, thyroid blood work should be repeated in 3 to 6 months before initiation of therapy as almost half of these patients have a resolution of the thyroid abnormalities.<xref ref-type="bibr" rid="article-29616.r17">[17]</xref>&#x000a0;</p>
        <p>TPO antibodies should be checked in patients.&#x000a0;If positive for TPO antibodies, this may indicate&#x000a0;an autoimmune etiology of hypothyroidism.<xref ref-type="bibr" rid="article-29616.r22">[22]</xref>&#x000a0;They correlate with a 2-fold increased risk of progression of subclinical hypothyroidism to overt hypothyroidism.<xref ref-type="bibr" rid="article-29616.r19">[19]</xref><xref ref-type="bibr" rid="article-29616.r23">[23]</xref>&#x000a0;The TPO antibody titers decrease with time and do not need repetition. An ultrasound&#x000a0;shows a&#x000a0;heterogenous and/or atrophic thyroid gland in patients with autoimmune thyroid disease, but this test is not recommended for establishing the diagnosis.<xref ref-type="bibr" rid="article-29616.r13">[13]</xref><xref ref-type="bibr" rid="article-29616.r24">[24]</xref>&#x000a0;Since subclinical hypothyroidism has potential associations with cardiovascular disease, congestive heart failure, and cognitive decline, patients should&#x000a0;be&#x000a0;evaluated for&#x000a0;the risk of atherosclerotic cardiovascular disease and other&#x000a0;comorbidities.<xref ref-type="bibr" rid="article-29616.r13">[13]</xref></p>
      </sec>
      <sec id="article-29616.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The central question in treating subclinical hypothyroidism is whether to and when to initiate levothyroxine therapy. This decision&#x000a0;is&#x000a0;challenging, especially for&#x000a0;older patients. The factors that need to be considered when deciding on levothyroxine therapy are age, extent of the elevation of TSH, associated cardiovascular risk factors, clinical symptoms of hypothyroidism, and presence of TPOAbs. As a significant proportion of patients with&#x000a0;subclinical hypothyroidism&#x000a0;have normalization of TSH levels, the first strategy is 'wait and watch.'&#x000a0;<xref ref-type="bibr" rid="article-29616.r25">[25]</xref>&#x000a0;Repeating TSH levels in 2 to 3 months is essential to confirm sustained elevation of TSH before hormone replacement&#x000a0;is initiated.</p>
        <p>Both the American Thyroid Association (ATA) and the American Association of Clinical Endocrinology (AACE) recommend starting levothyroxine therapy under the following scenarios:<xref ref-type="bibr" rid="article-29616.r22">[22]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>TSH is &#x0003e;10 mIU/L</p>
          </list-item>
          <list-item>
            <p>Presence of hypothyroid symptoms</p>
          </list-item>
          <list-item>
            <p>Positive TPO antibody</p>
          </list-item>
          <list-item>
            <p>Women of reproductive age</p>
          </list-item>
        </list>
        <p>The&#x000a0;age and cardiovascular status of patients should be considered.&#x000a0;Treatment is recommended&#x000a0;with levothyroxine in patients aged 70 or younger with TSH &#x0003e;10 mIU/L without a history of cardiovascular disease.<xref ref-type="bibr" rid="article-29616.r26">[26]</xref>&#x000a0;Patients with&#x000a0;subclinical hypothyroidism&#x000a0;do not need a full dose of levothyroxine replacement. Depending on the level of TSH elevation and symptoms, they can be started on 25 to 75 mcg levothyroxine. In individuals with a history of cardiovascular disease (without symptoms of active disease) and aged 70 or younger, the lowest dose of levothyroxine 25 mcg should be started to assess tolerability.</p>
        <p>In individuals aged 70 or older, the decision&#x000a0;is made on a case-by-case basis to initiate levothyroxine therapy based on symptoms and history of cardiovascular disease. Patients with TPO antibody positivity can also be started on levothyroxine replacement since these patients have a two-fold risk of progression to overt hypothyroidism. These recommendations do not apply to pregnant women or women trying to conceive. They should be started on levothyroxine replacement for mild thyroid dysfunction, especially when TPOAb is positive, due to a higher risk of worse pregnancy and fetal outcomes.<xref ref-type="bibr" rid="article-29616.r27">[27]</xref><xref ref-type="bibr" rid="article-29616.r28">[28]</xref><xref ref-type="bibr" rid="article-29616.r29">[29]</xref>&#x000a0;The threshold for replacement based on TSH values is also different in this population; further discussion on this topic is beyond the scope of this article.</p>
        <p>In the Thyroid Hormone Replacement for Untreated older adults with subclinical hypothyroidism&#x02014;a randomized placebo-controlled Trial (TRUST), a double-blinded, randomized, placebo-controlled trial, 737 adults who were aged 65 or older above with subclinical hypothyroidism (TSH between 4.60 and 19.99 mIU/L and free T4 within the reference range) were included. A total of 368 participants received low-dose levothyroxine of 50 mcg daily, except in patients with body weight less than 50 kg or a history of coronary artery disease. After&#x000a0;1 year, no difference was noted in the treatment and placebo groups for the hypothyroid symptoms scale and tiredness score. No differences were noted in terms of adverse effects.<xref ref-type="bibr" rid="article-29616.r30">[30]</xref></p>
        <p>A Cochrane review in 2017 involving 350 patients from 12 small clinical trials over 6 to 14 months did not show improvement in symptoms, mood, or quality of life metrics with levothyroxine replacement. Improvement was noted in the lipid profile and some echocardiographic parameters, including myocardial relaxation.&#x000a0;A difference in adverse events was reported in&#x000a0;4 clinical trials.<xref ref-type="bibr" rid="article-29616.r31">[31]</xref>&#x000a0;The Birmingham Elderly Thyroid Study, another randomized controlled trial by Parle et al in 94 community-dwelling individuals aged 65 or older, showed no improvement in cognitive function with low-dose levothyroxine replacement.<xref ref-type="bibr" rid="article-29616.r32">[32]</xref>&#x000a0;Grossman et al conducted a case-control study in 1558 individuals with subclinical hypothyroidism and TSH &#x0003c;10 mIU/L, showing an increased mortality risk with levothyroxine replacement. Factors associated with higher mortality were advanced age, senile dementia, history of cerebrovascular disease, congestive heart failure, and chronic renal failure. There was no higher risk of atrial fibrillation or femoral fractures.<xref ref-type="bibr" rid="article-29616.r33">[33]</xref></p>
        <p>Though multiple studies have shown an increased risk of cardiovascular disease and mortality in elderly patients with subclinical hypothyroidism, no long-term clinical trials have evaluated the effect of levothyroxine replacement on these factors.<xref ref-type="bibr" rid="article-29616.r34">[34]</xref>&#x000a0;Treatment decisions should not be based solely on these factors.</p>
      </sec>
      <sec id="article-29616.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several non-thyroid factors can transiently elevate TSH levels, potentially leading to misdiagnosis as subclinical hypothyroidism. It is crucial to differentiate between these causes of non-thyroidal TSH elevation and true subclinical hypothyroidism. These factors include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aging associated with a rise in TSH concentration&#x000a0;<xref ref-type="bibr" rid="article-29616.r35">[35]</xref><xref ref-type="bibr" rid="article-29616.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>Nonthyroidal illness&#x000a0;<xref ref-type="bibr" rid="article-29616.r37">[37]</xref><xref ref-type="bibr" rid="article-29616.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Laboratory assay interference&#x000a0;<xref ref-type="bibr" rid="article-29616.r39">[39]</xref><xref ref-type="bibr" rid="article-29616.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>Chronic renal failure</p>
          </list-item>
          <list-item>
            <p>Certain medications&#x000a0;such as amiodarone, lithium, tyrosine kinase inhibitors, checkpoint inhibitors, metoclopramide, amphetamine, ritonavir, and St Johns wort&#x000a0;<xref ref-type="bibr" rid="article-29616.r41">[41]</xref><xref ref-type="bibr" rid="article-29616.r42">[42]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29616.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Almost half of the patients with mild thyroid dysfunction have normalized thyroid function in 1 to 2 years. Almost 25% of these patients progress to overt hypothyroidism.<xref ref-type="bibr" rid="article-29616.r21">[21]</xref><xref ref-type="bibr" rid="article-29616.r43">[43]</xref>&#x000a0;An increase in cardiovascular risk factors, cardiovascular events and mortality, congestive heart failure, and decline in renal function is associated with a diagnosis of subclinical hypothyroidism.<xref ref-type="bibr" rid="article-29616.r44">[44]</xref><xref ref-type="bibr" rid="article-29616.r45">[45]</xref><xref ref-type="bibr" rid="article-29616.r46">[46]</xref></p>
      </sec>
      <sec id="article-29616.s10" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Cardiovascular Risk</bold>
</p>
        <p>Hypothyroidism is associated with increased vascular resistance and decreased cardiac output.<xref ref-type="bibr" rid="article-29616.r47">[47]</xref>&#x000a0;Lack of triiodothyronine (T3) impairs the vasodilatory action of nitric oxide on the vasculature, resulting in increased vascular resistance.<xref ref-type="bibr" rid="article-29616.r48">[48]</xref>&#x000a0;Thyroid hormones have positive chronotropic action by directly stimulating the sinoatrial node and positive&#x000a0;inotropic effect by modulating myocyte-specific regulatory proteins, increasing cardiac contractility. Lack of thyroid hormone results in bradycardia and decreased cardiac output.<xref ref-type="bibr" rid="article-29616.r49">[49]</xref><xref ref-type="bibr" rid="article-29616.r50">[50]</xref>&#x000a0;</p>
        <p>Rodondi et al studied 55,000 patients in a prospective cohort study and found that a TSH between 10.0&#x000a0;and 19.9&#x000a0;mIU/L correlated with an increased risk of coronary artery disease events (hazard ratio of 1.86;&#x000a0;CI 1.28-2.80) and cardiovascular mortality (Hazard ratio of 1.58; CI 1.10-2.27).<xref ref-type="bibr" rid="article-29616.r51">[51]</xref>&#x000a0;However, Gusekloo et al showed that in older individuals (aged 85 or older), higher TSH levels&#x000a0;were associated with a reduced mortality rate.<xref ref-type="bibr" rid="article-29616.r52">[52]</xref>&#x000a0;Rodondi et al studied 2730 individuals between the ages of 70 and 79 over a 4-year follow-up period and found a higher risk of congestive heart failure with TSH levels of 7.0 mIU/L or higher.<xref ref-type="bibr" rid="article-29616.r53">[53]</xref>&#x000a0;Adrees et al showed that the increased levels of systolic blood pressure (SBP) and diastolic BP (DBP), total cholesterol, triglyceride, LDL-cholesterol, lipoprotein(a), homocysteine, and carotid intima-media thickness were associated with subclinical hypothyroidism in 54 women, which normalized after 18 months of levothyroxine treatment and became similar to euthyroid women.<xref ref-type="bibr" rid="article-29616.r54">[54]</xref></p>
        <p>
<bold>Functional Capacity</bold>
</p>
        <p>Subclinical hypothyroidism has been associated with decreased muscular strength and exercise capacity. Mainenti et al randomized 23 women with subclinical hypothyroidism to receive levothyroxine or placebo. After&#x000a0;6 months of TSH normalization, an increase in exercise performance was noted in the treatment group.<xref ref-type="bibr" rid="article-29616.r55">[55]</xref></p>
        <p>
<bold>Cognitive Impairment</bold>
</p>
        <p>Hypothyroidism&#x000a0;is associated with cognitive decline. Triiodothyronine plays a vital role in neuronal growth, migration, and myelination. However, studies have yielded conflicting results on the association of subclinical hypothyroidism and cognitive impairment. Pasqualetti et al, in their meta-analysis of 13 studies, found an increased risk of cognitive decline in patients aged 75 or younger with subclinical hypothyroidism.<xref ref-type="bibr" rid="article-29616.r56">[56]</xref>&#x000a0;In contrast, Akintola&#x000a0;et al, in their meta-analysis of 15 studies, found no increased risk of cognitive impairment with subclinical hypothyroidism.<xref ref-type="bibr" rid="article-29616.r57">[57]</xref></p>
        <p>
<bold>Mood Disturbances</bold>
</p>
        <p>A meta-analysis by Zhao et al found an association between&#x000a0;subclinical hypothyroidism&#x000a0;and depression in participants aged 60 or younger and no association in individuals aged 60 or older. No change in depression scores was apparent with levothyroxine replacement.<xref ref-type="bibr" rid="article-29616.r58">[58]</xref>&#x000a0;Another meta-analysis by Loh et al involving&#x000a0;12,315 individuals also found a 1.7 times higher risk of depression scores associated with a diagnosis of subclinical hypothyroidism.<xref ref-type="bibr" rid="article-29616.r59">[59]</xref></p>
        <p>
<bold>Renal Function</bold>
</p>
        <p>Chonchol et al found the prevalence of&#x000a0;subclinical hypothyroidism in patients with chronic kidney disease (CKD), not on dialysis, to be 18%. The presence of&#x000a0;subclinical hypothyroidism in this population was associated with a progressive decline in the estimated glomerular filtration rate over&#x000a0;2 years.<xref ref-type="bibr" rid="article-29616.r60">[60]</xref>&#x000a0;Adrees et al showed that the decreased levels of estimated glomerular filtration rate and increased serum cystatin-C levels were associated with SH in 54 women, and treatment with hypothyroidism led to these levels becoming comparable to&#x000a0;levels in euthyroid women.<xref ref-type="bibr" rid="article-29616.r54">[54]</xref></p>
      </sec>
      <sec id="article-29616.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be counseled regarding the symptoms of hypothyroidism. They must be advised regarding treatment outcomes when TSH is below and above 10 mIU/L. Patients above 70 mIU/L with mild TSH elevation should be informed regarding the aging-related mild elevation in TSH concentrations, along with the lack of improvement shown in studies. Given the higher risk of cardiovascular risk factors, cardiovascular events, and morality, lifestyle changes should be advised.&#x000a0;</p>
      </sec>
      <sec id="article-29616.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Below are pertinent pearls for managing subclinical hypothyroidism:</p>
        <list list-type="bullet">
          <list-item>
            <p>Subclinical hypothyroidism characteristically has an elevated TSH and normal T4. While most patients are asymptomatic, some may have symptoms of hypothyroidism.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Subclinical hypothyroidism requires differentiation from other causes of a transient elevation of TSH (age, medications, renal failure, non-thyroidal illness, and assay interference).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Subclinical hypothyroidism has potential correlations with an&#x000a0;increased risk of cardiovascular disease, cognitive decline, and decreased functional capacity.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Treatment with levothyroxine should commence if the level of TSH is &#x0003e;10 mIU/L, with positive TPOAb, hypothyroid symptoms, or cardiovascular risk factors.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29616.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional healthcare team is the best approach to subclinical hypothyroidism management.&#x000a0;The central question in treating subclinical hypothyroidism is when to&#x000a0;initiate&#x000a0;levothyroxine therapy. Factors that need to be considered when deciding on levothyroxine therapy are age, the extent of the elevation of TSH, associated cardiovascular risk factors, clinical symptoms of hypothyroidism, and the presence of TPOAbs.</p>
      </sec>
      <sec id="article-29616.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29616&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29616">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/subclinical-hypothyroidism/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29616">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29616/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29616">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29616.s15">
        <title>References</title>
        <ref id="article-29616.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Subclinical hypothyroidism.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Jul</month>
            <day>26</day>
            <volume>345</volume>
            <issue>4</issue>
            <fpage>260</fpage>
            <page-range>260-5</page-range>
            <pub-id pub-id-type="pmid">11474665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baloch</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Carayon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Conte-Devolx</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Demers</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Feldt-Rasmussen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>LiVosli</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Niccoli-Sire</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ruf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smyth</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Stockigt</surname>
                <given-names>JR</given-names>
              </name>
              <collab>Guidelines Committee, National Academy of Clinical Biochemistry</collab>
            </person-group>
            <article-title>Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.</article-title>
            <source>Thyroid</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-126</page-range>
            <pub-id pub-id-type="pmid">12625976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bruun</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Laurberg</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>1068</fpage>
            <page-range>1068-72</page-range>
            <pub-id pub-id-type="pmid">11889165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rothacker</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Hadlow</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Wardrop</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Reconciling the Log-Linear and Non-Log-Linear Nature of the TSH-Free T4 Relationship: Intra-Individual Analysis of a Large Population.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>1151</fpage>
            <page-range>1151-8</page-range>
            <pub-id pub-id-type="pmid">26735261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canaris</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Manowitz</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Mayor</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ridgway</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>The Colorado thyroid disease prevalence study.</article-title>
            <source>Arch Intern Med</source>
            <year>2000</year>
            <month>Feb</month>
            <day>28</day>
            <volume>160</volume>
            <issue>4</issue>
            <fpage>526</fpage>
            <page-range>526-34</page-range>
            <pub-id pub-id-type="pmid">10695693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanderpump</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Tunbridge</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Appleton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Grimley Evans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hasan</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tunbridge</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-68</page-range>
            <pub-id pub-id-type="pmid">7641412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hollowell</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Staehling</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Flanders</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hannon</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Gunter</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>489</fpage>
            <page-range>489-99</page-range>
            <pub-id pub-id-type="pmid">11836274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>den Elzen</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Ikram</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dehghan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Drechsler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Luben</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Hofman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Portegies</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Medici</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iervasi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stott</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bremner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wanner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferrucci</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Dullaart</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Sgarbi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ceresini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maciel</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Westendorp</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Jukema</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Imaizumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franklyn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Cappola</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lzke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Gussekloo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>RP</given-names>
              </name>
              <collab>Thyroid Studies Collaboration</collab>
            </person-group>
            <article-title>Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>2181</fpage>
            <page-range>2181-91</page-range>
            <pub-id pub-id-type="pmid">25856213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collet</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Gussekloo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>den Elzen</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Cappola</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Balmer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iervasi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>&#x000c5;svold</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Sgarbi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lzke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gencer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maciel</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Molinaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bremner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Luben</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Maisonneuve</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cornuz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Westendorp</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Franklyn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Vittinghoff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <collab>Thyroid Studies Collaboration</collab>
            </person-group>
            <article-title>Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.</article-title>
            <source>Arch Intern Med</source>
            <year>2012</year>
            <month>May</month>
            <day>28</day>
            <volume>172</volume>
            <issue>10</issue>
            <fpage>799</fpage>
            <page-range>799-809</page-range>
            <pub-id pub-id-type="pmid">22529182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Cappola</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Cornuz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robbins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Ladenson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Vittinghoff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gottdiener</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2008</year>
            <month>Sep</month>
            <day>30</day>
            <volume>52</volume>
            <issue>14</issue>
            <fpage>1152</fpage>
            <page-range>1152-9</page-range>
            <pub-id pub-id-type="pmid">18804743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuentes</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Pineda</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Venkata</surname>
                <given-names>KCN</given-names>
              </name>
            </person-group>
            <article-title>Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice.</article-title>
            <source>Pharmacy (Basel)</source>
            <year>2018</year>
            <month>May</month>
            <day>14</day>
            <volume>6</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29757930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Korevaar</surname>
                <given-names>TIM</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Trends, Determinants, and Associations of Treated Hypothyroidism in the United Kingdom, 2005-2014.</article-title>
            <source>Thyroid</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>174</fpage>
            <page-range>174-182</page-range>
            <pub-id pub-id-type="pmid">30501570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peeters</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Jun</month>
            <day>29</day>
            <volume>376</volume>
            <issue>26</issue>
            <fpage>2556</fpage>
            <page-range>2556-2565</page-range>
            <pub-id pub-id-type="pmid">28657873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bensenor</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Hypothyroidism.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2022</year>
            <month>May</month>
            <day>19</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">35589725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Teng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Causal Association Between Serum Thyrotropin and Obesity: A Bidirectional, Mendelian Randomization Study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2021</year>
            <month>Sep</month>
            <day>27</day>
            <volume>106</volume>
            <issue>10</issue>
            <fpage>e4251</fpage>
            <page-range>e4251-e4259</page-range>
            <pub-id pub-id-type="pmid">33754627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agnihothri</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Courville</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Linderman</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brychta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Remaley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Simchowitz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Celi</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Moderate weight loss is sufficient to affect thyroid hormone homeostasis and inhibit its peripheral conversion.</article-title>
            <source>Thyroid</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-26</page-range>
            <pub-id pub-id-type="pmid">23902316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pearce</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Brabant</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Duntas</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Monzani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wemeau</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>2013 ETA Guideline: Management of Subclinical Hypothyroidism.</article-title>
            <source>Eur Thyroid J</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>215</fpage>
            <page-range>215-28</page-range>
            <pub-id pub-id-type="pmid">24783053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Teng</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>e0135233</fpage>
            <pub-id pub-id-type="pmid">26270348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huber</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Staub</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mitrache</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guglielmetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>87</volume>
            <issue>7</issue>
            <fpage>3221</fpage>
            <page-range>3221-6</page-range>
            <pub-id pub-id-type="pmid">12107228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somwaru</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Rariy</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cappola</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>6</issue>
            <fpage>1962</fpage>
            <page-range>1962-9</page-range>
            <pub-id pub-id-type="pmid">22438233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D&#x000ed;ez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Iglesias</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>89</volume>
            <issue>10</issue>
            <fpage>4890</fpage>
            <page-range>4890-7</page-range>
            <pub-id pub-id-type="pmid">15472181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garber</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Cobin</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Gharib</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hennessey</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mechanick</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Pessah-Pollack</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Woeber</surname>
                <given-names>KA</given-names>
              </name>
              <collab>American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults</collab>
            </person-group>
            <article-title>Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.</article-title>
            <source>Endocr Pract</source>
            <year>2012</year>
            <season>Nov-Dec</season>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>988</fpage>
            <page-range>988-1028</page-range>
            <pub-id pub-id-type="pmid">23246686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caturegli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Remigis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Hashimoto thyroiditis: clinical and diagnostic criteria.</article-title>
            <source>Autoimmun Rev</source>
            <year>2014</year>
            <season>Apr-May</season>
            <volume>13</volume>
            <issue>4-5</issue>
            <fpage>391</fpage>
            <page-range>391-7</page-range>
            <pub-id pub-id-type="pmid">24434360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ragusa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fallahi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Elia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gonnella</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Paparo</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Giusti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Churilov</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>101367</fpage>
            <pub-id pub-id-type="pmid">31812326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calissendorff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2020</year>
            <month>Jan</month>
            <day>19</day>
            <volume>56</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31963883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livingston</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>Jul</month>
            <day>09</day>
            <volume>322</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <pub-id pub-id-type="pmid">31287524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casey</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Thom</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Peaceman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Varner</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Sorokin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hirtz</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>UM</given-names>
              </name>
              <name>
                <surname>Wapner</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Thorp</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Saade</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tita</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Sibai</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iams</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Tolosa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Caritis</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>VanDorsten</surname>
                <given-names>JP</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal&#x02013;Fetal Medicine Units Network</collab>
            </person-group>
            <article-title>Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Mar</month>
            <day>02</day>
            <volume>376</volume>
            <issue>9</issue>
            <fpage>815</fpage>
            <page-range>815-825</page-range>
            <pub-id pub-id-type="pmid">28249134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abalovich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gutierrez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alcaraz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maccallini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Levalle</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Overt and subclinical hypothyroidism complicating pregnancy.</article-title>
            <source>Thyroid</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-8</page-range>
            <pub-id pub-id-type="pmid">11838732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maraka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ospina</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>O'Keeffe</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Espinosa De Ycaza</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Gionfriddo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Coddington</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>580</fpage>
            <page-range>580-90</page-range>
            <pub-id pub-id-type="pmid">26837268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stott</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Westendorp</surname>
                <given-names>RGJ</given-names>
              </name>
              <name>
                <surname>Mooijaart</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Sattar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aubert</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Aujesky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Browne</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Dekkers</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>den Elzen</surname>
                <given-names>WPJ</given-names>
              </name>
              <name>
                <surname>Du Puy</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Feller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Floriani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hendry</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hurley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jukema</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kean</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krebs</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Langhorne</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>McConnachie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McDade</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Messow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Flynn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Riordan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Poortvliet</surname>
                <given-names>RKE</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sinnott</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smit</surname>
                <given-names>JWA</given-names>
              </name>
              <name>
                <surname>Van Dorland</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Watt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gussekloo</surname>
                <given-names>J</given-names>
              </name>
              <collab>TRUST Study Group</collab>
            </person-group>
            <article-title>Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Jun</month>
            <day>29</day>
            <volume>376</volume>
            <issue>26</issue>
            <fpage>2534</fpage>
            <page-range>2534-2544</page-range>
            <pub-id pub-id-type="pmid">28402245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villar</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Saconato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Atallah</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Thyroid hormone replacement for subclinical hypothyroidism.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2007</year>
            <month>Jul</month>
            <day>18</day>
            <volume>2007</volume>
            <issue>3</issue>
            <fpage>CD003419</fpage>
            <pub-id pub-id-type="pmid">17636722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pattison</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Roalfe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haque</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franklyn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>95</volume>
            <issue>8</issue>
            <fpage>3623</fpage>
            <page-range>3623-32</page-range>
            <pub-id pub-id-type="pmid">20501682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grossman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feldhamer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Meyerovitch</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly.</article-title>
            <source>Eur J Intern Med</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>50</volume>
            <fpage>65</fpage>
            <page-range>65-68</page-range>
            <pub-id pub-id-type="pmid">29174213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bekkering</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Agoritsas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lytvyn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Heen</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Feller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moutzouri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Abdulazeem</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aertgeerts</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Beecher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brito</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Farhoumand</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Singh Ospina</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van Driel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Snel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okwen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Siemieniuk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vandvik</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Kuijpers</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vermandere</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline.</article-title>
            <source>BMJ</source>
            <year>2019</year>
            <month>May</month>
            <day>14</day>
            <volume>365</volume>
            <fpage>l2006</fpage>
            <pub-id pub-id-type="pmid">31088853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bremner</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Feddema</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leedman</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Beilby</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>O'Leary</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Age-related changes in thyroid function: a longitudinal study of a community-based cohort.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>May</month>
            <volume>97</volume>
            <issue>5</issue>
            <fpage>1554</fpage>
            <page-range>1554-62</page-range>
            <pub-id pub-id-type="pmid">22344200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leng</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hypothyroidism in the older population.</article-title>
            <source>Thyroid Res</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">30774717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Beckett</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms behind the non-thyroidal illness syndrome: an update.</article-title>
            <source>J Endocrinol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>205</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">20016054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farwell</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Nonthyroidal illness syndrome.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>478</fpage>
            <page-range>478-84</page-range>
            <pub-id pub-id-type="pmid">23974778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Favresse</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burlacu</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Maiter</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gruson</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm.</article-title>
            <source>Endocr Rev</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>830</fpage>
            <page-range>830-850</page-range>
            <pub-id pub-id-type="pmid">29982406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koulouri</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Halsall</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gurnell</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pitfalls in the measurement and interpretation of thyroid function tests.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>745</fpage>
            <page-range>745-62</page-range>
            <pub-id pub-id-type="pmid">24275187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamine</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Giorgi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Michalaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sykiotis</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Subclinical hypothyroidism: new trials, old caveats.</article-title>
            <source>Hormones (Athens)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>231</fpage>
            <page-range>231-236</page-range>
            <pub-id pub-id-type="pmid">29858848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizzo</surname>
                <given-names>LFL</given-names>
              </name>
              <name>
                <surname>Mana</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Serra</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced hypothyroidism.</article-title>
            <source>Medicina (B Aires)</source>
            <year>2017</year>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>394</fpage>
            <page-range>394-404</page-range>
            <pub-id pub-id-type="pmid">29044016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D&#x000ed;ez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Iglesias</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>90</volume>
            <issue>7</issue>
            <fpage>4124</fpage>
            <page-range>4124-7</page-range>
            <pub-id pub-id-type="pmid">15811925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delitala</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Fanciulli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maioli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delitala</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Subclinical hypothyroidism, lipid metabolism and cardiovascular disease.</article-title>
            <source>Eur J Intern Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>38</volume>
            <fpage>17</fpage>
            <page-range>17-24</page-range>
            <pub-id pub-id-type="pmid">28040402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inoue</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ritz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brent</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Ebrahimi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality.</article-title>
            <source>JAMA Netw Open</source>
            <year>2020</year>
            <month>Feb</month>
            <day>05</day>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>e1920745</fpage>
            <pub-id pub-id-type="pmid">32031647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Vanderpump</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>1734</fpage>
            <page-range>1734-40</page-range>
            <pub-id pub-id-type="pmid">20150579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biondi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Palmieri</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fazio</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Subclinical hypothyroidism and cardiac function.</article-title>
            <source>Thyroid</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>505</fpage>
            <page-range>505-10</page-range>
            <pub-id pub-id-type="pmid">12165114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jabbar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pingitore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Danzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biondi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zaman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iervasi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Thyroid Hormones and Cardiovascular Function and Diseases.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2018</year>
            <month>Apr</month>
            <day>24</day>
            <volume>71</volume>
            <issue>16</issue>
            <fpage>1781</fpage>
            <page-range>1781-1796</page-range>
            <pub-id pub-id-type="pmid">29673469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>ZQ</given-names>
              </name>
              <name>
                <surname>Ojamaa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coetzee</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Artman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes.</article-title>
            <source>Am J Physiol Endocrinol Metab</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>278</volume>
            <issue>2</issue>
            <fpage>E302</fpage>
            <page-range>E302-7</page-range>
            <pub-id pub-id-type="pmid">10662715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ojamaa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Thyroid hormone and the cardiovascular system.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Feb</month>
            <day>15</day>
            <volume>344</volume>
            <issue>7</issue>
            <fpage>501</fpage>
            <page-range>501-9</page-range>
            <pub-id pub-id-type="pmid">11172193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>den Elzen</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Cappola</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Razvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Asvold</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Iervasi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Imaizumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Bremner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maisonneuve</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sgarbi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Vanderpump</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Cornuz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Franklyn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Westendorp</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Vittinghoff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gussekloo</surname>
                <given-names>J</given-names>
              </name>
              <collab>Thyroid Studies Collaboration</collab>
            </person-group>
            <article-title>Subclinical hypothyroidism and the risk of coronary heart disease and mortality.</article-title>
            <source>JAMA</source>
            <year>2010</year>
            <month>Sep</month>
            <day>22</day>
            <volume>304</volume>
            <issue>12</issue>
            <fpage>1365</fpage>
            <page-range>1365-74</page-range>
            <pub-id pub-id-type="pmid">20858880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gussekloo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Exel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Craen</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Meinders</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Fr&#x000f6;lich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Westendorp</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Thyroid status, disability and cognitive function, and survival in old age.</article-title>
            <source>JAMA</source>
            <year>2004</year>
            <month>Dec</month>
            <day>01</day>
            <volume>292</volume>
            <issue>21</issue>
            <fpage>2591</fpage>
            <page-range>2591-9</page-range>
            <pub-id pub-id-type="pmid">15572717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodondi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Vittinghoff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Rekeneire</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Satterfield</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.</article-title>
            <source>Arch Intern Med</source>
            <year>2005</year>
            <month>Nov</month>
            <day>28</day>
            <volume>165</volume>
            <issue>21</issue>
            <fpage>2460</fpage>
            <page-range>2460-6</page-range>
            <pub-id pub-id-type="pmid">16314541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adrees</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gibney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El-Saeity</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boran</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>298</fpage>
            <page-range>298-303</page-range>
            <pub-id pub-id-type="pmid">19094068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mainenti</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Vig&#x000e1;rio</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Vaisman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effect of levothyroxine replacement on exercise performance in subclinical hypothyroidism.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2009</year>
            <month>May</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>470</fpage>
            <page-range>470-3</page-range>
            <pub-id pub-id-type="pmid">19468264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasqualetti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pagano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rengo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferrara</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Monzani</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism and Cognitive Impairment: Systematic Review and Meta-Analysis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>100</volume>
            <issue>11</issue>
            <fpage>4240</fpage>
            <page-range>4240-8</page-range>
            <pub-id pub-id-type="pmid">26305618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akintola</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>van Bodegom</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van der Grond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Westendorp</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>de Craen</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>van Heemst</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis.</article-title>
            <source>Front Aging Neurosci</source>
            <year>2015</year>
            <volume>7</volume>
            <fpage>150</fpage>
            <pub-id pub-id-type="pmid">26321946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>ZY</given-names>
              </name>
            </person-group>
            <article-title>Subclinical hypothyroidism and depression: a meta-analysis.</article-title>
            <source>Transl Psychiatry</source>
            <year>2018</year>
            <month>Oct</month>
            <day>30</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>239</fpage>
            <pub-id pub-id-type="pmid">30375372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loh</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Loh</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis.</article-title>
            <source>BMC Psychiatry</source>
            <year>2019</year>
            <month>Jan</month>
            <day>08</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">30621645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29616.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chonchol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salvagno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zoppini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Muggeo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Targher</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of subclinical hypothyroidism in patients with chronic kidney disease.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>1296</fpage>
            <page-range>1296-300</page-range>
            <pub-id pub-id-type="pmid">18550654</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
